Ashton Thomas Securities’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.24M Sell
7,827
-68
-0.9% -$10.1K 0.18% 119
2026
Q1
$1.16M Sell
7,895
-1,216
-13% -$188K 0.15% 155
2025
Q4
$1.41M Buy
9,111
+722
+9% +$108K 0.27% 83
2025
Q3
$1.17M Sell
8,389
-3,223
-28% -$436K 0.16% 134
2025
Q2
$1.57M Sell
11,612
-668
-5% -$90.2K 0.38% 71
2025
Q1
$1.79M Sell
12,280
-1,884
-13% -$274K 0.5% 56
2024
Q4
$1.95M Buy
14,164
+2,013
+17% +$295K 0.54% 47
2024
Q3
$1.87M Sell
12,151
-526
-4% -$79.7K 0.36% 70
2024
Q2
$1.82M Buy
+12,677
New +$1.82M 0.44% 62

Other funds holding XLV

Ashton Thomas Securities's XLV Position: Q2 2026 in Review

Ashton Thomas Securities reduced its State Street Health Care Select Sector SPDR ETF (XLV) stake by 0.86% in Q2 2026, selling an estimated $10.1K and leaving 7,827 shares worth $1.24M. The position accounts for 0.18% of the portfolio, ranked #119.

Ashton Thomas Securities first reported a position in XLV in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.95M in Q4 2024. 1,852 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

  • Ashton Thomas Securities held 7,827 shares of State Street Health Care Select Sector SPDR ETF worth $1.24M as of Q2 2026.
  • Ashton Thomas Securities sold 68 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $10.1K.
  • State Street Health Care Select Sector SPDR ETF made up 0.18% of Ashton Thomas Securities's portfolio in Q2 2026, its #119 holding.
  • Ashton Thomas Securities first reported a position in State Street Health Care Select Sector SPDR ETF in Q2 2024 and has held it in 9 quarters since.
  • Ashton Thomas Securities's State Street Health Care Select Sector SPDR ETF position peaked at $1.95M in Q4 2024.
  • 1,852 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on Ashton Thomas Securities's 13F filing for Q2 2026, filed 27 Jul 2026.